Frederick M. Hudson - 19 Feb 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
19 Feb 2025
Net transactions value
$0
Form type
4
Filing time
21 Feb 2025, 16:51:48 UTC
Previous filing
23 Jan 2025
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 48,395 19 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Award $0 +7,296 $0.000000 7,296 19 Feb 2025 Common Stock 7,296 $33.52 Direct F1
transaction SUPN Restricted Stock Unit Award $0 +4,475 $0.000000 4,475 19 Feb 2025 Common Stock 4,475 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on February 19, 2026.
F2 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F3 These restricted stock units will be settled in common stock upon vesting, which will occur on February 19, 2026.